DKSH signs distribution agreement with Johnson Matthey in Japan

Published: 22-Mar-2018

DKSH, a Market Expansion Services provider with a focus on Asia, and Johnson Matthey, a science specialist looking to enable cleaner air, improved health and more efficient use of natural resources, have joined forces to provide a wide range of products in Japan

DKSH’s Business Unit Performance Materials, an ingredients and specialty chemicals distributor, has been selected as the exclusive distributor in Japan for Johnson Matthey’s broad spectrum of biocatalysts, advanced homogeneous and heterogeneous catalysts as well as associated platinum metal ligands.

Under the agreement, DKSH will market and distribute Johnson Matthey’s extensive product portfolio to pharmaceutical and fine chemical companies throughout Japan. The innovative range of catalysts accelerates reactions and optimises processes that are more efficient, selective and sustainable.

Johnson Matthey has more than 200 years of experience in solving complex chemistry challenges to build a healthier world. Its specialist technologies and capabilities provide a substantial toolkit for diverse chemical reactions.

DKSH was chosen for its solid logistics infrastructure and proven experience in providing Market Expansion Services along the entire value chain. DKSH has an uninterrupted history in Japan for more than 150 years and is a leading player in today’s Japanese pharmaceutical market for intermediates and APIs.

Shigeru Ishihara, Director, Performance Materials, DKSH Japan, said: “We are very pleased to exclusively partner with Johnson Matthey in Japan. Their advanced catalysts will greatly benefit our long-standing customer base by improving their chemistry and production process, while as reducing cost and production waste. We look forward to a long and successful relationship.”

“We are delighted to partner with DKSH as it has a first-class reputation and extensive local knowledge of Japan”, commented Gerard Compagnoni, General Manager, Johnson Matthey.

“We are excited to deliver our world-leading catalytic technologies to the pharmaceutical and fine chemical industries in this region.”

You may also like